Our Collaborators

PAHO collaborates with a number of academic institutions and organizations on the development of economic evaluation tools, trainings and technical assistance. These include:

  • London School of Hygiene and Tropical Medicine
  • Harvard School of Public Health’s Center for Health Decision Science
  • Rutgers University
  • Universidade Federal de Goias
  • Instituto de Efectividad Clinica y Sanitaria*
  • Universidad Nacional de Colombia*
  • Universidade de São Paulo*
  • Universidade Estatal do Rio de Janiero*
  • Universidad de Cartagena*

The Bill and Melinda Gates Foundation awarded PAHO with a multi-year grant to accelerate the work of ProVac in 2009. In 2010, a network of academic centers of excellence* was established to promote evidence-based vaccine policy in the Americas by bridging between research and policy. From 2011-2013, a partner collaboration named the ProVac International Working Group (IWG) was established to transfer the tools and framework of ProVac to non-PAHO Regions. Sabin Vaccine Institute (Sabin), the US Centers for Disease Control (CDC), PATH and Agence de Medecine Préventive (AMP) were members of the ProVac IWG and contributed to extending the ProVac Initiative to thirteen countries across three regions, including Africa, Asia and Europe.


This post is also available in: French Spanish

PAHO’s ProVac Initiative

Promotion of evidence-based decision making for the introduction of new vaccines. A well regarded suite of tools, including Excel-based models, guidance/training tools and data sources, is summarized in this toolkit to help countries estimate vaccine costs, impact and cost-effectiveness to inform the national decision making process on new vaccines.